Covered recipient · General Payments record
ASHA PRABHU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$3,046.10
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.28 | 26 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.34 | 12 |
| Teva Pharmaceuticals USA, Inc. | $64.75 | 4 |
| Alkermes, Inc. | $53.53 | 3 |
| Supernus Pharmaceuticals, Inc. | $31.71 | 1 |
| Lundbeck LLC | $29.04 | 2 |
| Corium, Inc. | $24.88 | 2 |
| Neurocrine BioSciences, Inc. | $18.12 | 1 |
| ITI, Inc. | $17.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.90 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159797 | CMS |
| ABBVIE INC. | $8.89 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159799 | CMS |
| ABBVIE INC. | $19.27 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159801 | CMS |
| ABBVIE INC. | $6.73 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159803 | CMS |
| ABBVIE INC. | $8.33 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159805 | CMS |
| ABBVIE INC. | $9.09 | 07/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159807 | CMS |
| ABBVIE INC. | $9.77 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159809 | CMS |
| ABBVIE INC. | $2.69 | 07/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159811 | CMS |
| ABBVIE INC. | $25.15 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159813 | CMS |
| ABBVIE INC. | $8.91 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159815 | CMS |
| ABBVIE INC. | $2.87 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159817 | CMS |
| ABBVIE INC. | $32.74 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998159819 | CMS |
| Alkermes, Inc. | $15.58 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022897199 | CMS |
| Alkermes, Inc. | $18.11 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022897201 | CMS |
| Alkermes, Inc. | $19.84 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022897203 | CMS |
| Corium, LLC | $11.92 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 977983257 | CMS |
| Corium, LLC | $12.96 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978475903 | CMS |
| ITI, Inc. | $17.91 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040661123 | CMS |
| Lundbeck LLC | $15.08 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032320675 | CMS |
| Lundbeck LLC | $13.96 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032320685 | CMS |
| Neurocrine Biosciences, Inc. | $18.12 | 08/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052226215 | CMS |
| Supernus Pharmaceuticals, Inc. | $31.71 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053298017 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.06 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056775147 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.05 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056775173 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.01 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056775191 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.63 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056775183 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.